|SEQ_NO||1||Date of announcement||2021/12/10||Time of announcement||15:34:48|
|Subject||Announcement of TTY Biopharm's unaudited income information in November 2021|
|Date of events||2021/12/10||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/12/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $430,974 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $100,002 thousands, and a consolidated income before tax of $111,362 thousands in November 2021; net income attributed to stockholders of the parent company was $87,375 thousands; EPS is $0.35.
Year-to-date consolidated net sales was $4,062,985 thousands (in NT dollars; unaudited), a consolidated operating profit was $819,538 thousands and consolidated income before tax was $957,181 thousands until November 2021; year-to-date net income attributed to stockholders of the company was $716,854 thousands; EPS is $2.88.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.